NCT05880576
The Arch Watch Study: An Integrated Evaluation of Hemodynamics in Infants With Suspected Coarctation of the Aorta
Enrolling by Invitation
Not specifiedAges 0–60ObservationalBoston Children's HospitalInvestigator-initiated
~60 participants
Updated 2026-06-29 on ClinicalTrials.gov
What's tested:Monitoring using resonance Raman spectroscopy, pulse oximetry, blood pressure, and near-infrared spectroscopy
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Number of participants with arch or CoA repair
Measured over First 3 postnatal months
Conditions
NCT05880576
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Boston Children's Hospital
Boston, Massachusettsno site contact published
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- John Kheir, MD · PRINCIPAL_INVESTIGATOR · Boston Children's Hospital
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Infants with echocardiography-based possible or definite aortic arch obstruction and \<1 month postnatal age admitted to the CICU
Exclusion
Known carrier status for resistant organisms. Resistant organisms are defined as MRSA and VRE.
What this trial measures
- Number of participants with arch or CoA repairFirst 3 postnatal months
Surgical or catheter-based repair of the aortic arch or coarctation of the aorta